REAL3: A multicenter randomized phase II/III trial of epirubicin, oxaliplatin, and capecitabine (EOC) versus modified (m) EOC plus panitumumab (P) in advanced oesophagogastric (OG) cancer-Response rate (RR), toxicity, and molecular analysis from phase II.

Autoria(s): Chau, I.; Okines, A.F.C.; de Castro, D.G.; Saffery, C.; Barbachano, Y.; Wotherspoon, A.; Puckey, L.; Wilson, S.H.; Coxon, F.Y.; Middleton, G.W.; Ferry, D.R.; Crosby, T.D.L.; Madhusudan, S.; Wadsley, J.; Waters, J.S.; Hall, M.; Swinson, D.; Robinson, A.; Smith, D.; Cunningham, D.; Gastro, U.K.N.C.R.I.U.
Data(s)

20/05/2011
Identificador

http://pure.qub.ac.uk/portal/en/publications/real3-a-multicenter-randomized-phase-iiiii-trial-of-epirubicin-oxaliplatin-and-capecitabine-eoc-versus-modified-m-eoc-plus-panitumumab-p-in-advanced-oesophagogastric-og-cancerresponse-rate-rr-toxicity-and-molecular-analysis-from-phase-ii(2c7f3049-187a-4390-8dee-04d062ca7ae0).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Chau , I , Okines , A F C , de Castro , D G , Saffery , C , Barbachano , Y , Wotherspoon , A , Puckey , L , Wilson , S H , Coxon , F Y , Middleton , G W , Ferry , D R , Crosby , T D L , Madhusudan , S , Wadsley , J , Waters , J S , Hall , M , Swinson , D , Robinson , A , Smith , D , Cunningham , D & Gastro , U K N C R I U 2011 , ' REAL3: A multicenter randomized phase II/III trial of epirubicin, oxaliplatin, and capecitabine (EOC) versus modified (m) EOC plus panitumumab (P) in advanced oesophagogastric (OG) cancer-Response rate (RR), toxicity, and molecular analysis from phase II. ' Journal of Clinical Oncology , vol 29 , no. 15 .
Tipo

article
Acesso ao item digital